The Pancreatic Duct Ligated (Mini)pig as a Model for Pancreatic Exocrine Insufficiency in Man.
Modern therapy of pancreatic exocrine insufficiency (PEI) using pancreatic enzyme replacement therapy (PERT) has largely been very effective and has greatly helped in improving the nutritional status of patients with PEI and in increasing the life expectancy in cystic fibrosis. It is believed that the use of predictable large animal models could play an important role in assessing and developing new therapies. This article reviews the pancreatic duct ligated (adult) minipig as a chronic model of total PEI, with a detailed look at the influence of PEI and response to PERT on prececal compared to fecal digestibility, to directly investigate effects on protein and starch digestion and absorption. In addition, the piglet with PEI is reviewed as a model for PEI in young patients with the aim of further improving the therapy and nutritional status of young patients with cystic fibrosis.
From the *Abbott Laboratories GmbH; and †Institute for Animal Nutrition, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.
Peter Colin
PC
Gregory
Katrin
K
Hoffmann
Josef
J
Kamphues
Anne
A
Möeler
D000818:Animals; D003550:Cystic Fibrosis; D056947:Enzyme Replacement Therapy; D010188:Exocrine Pancreatic Insufficiency; D010183:Pancreatic Ducts; D013552:Swine; D013556:Swine, Miniature